Use a Checklist to Monitor Patients on DOACs

October 2015

We're getting questions about how to monitor patients on direct oral anticoagulants...Pradaxa, Xarelto, Eliquis, and Savaysa.

We know these "DOACs" (Direct Oral AntiCoagulants) don't have good lab tests to assess efficacy and bleeding risk...like INR with warfarin.

But they still need clinical monitoring to ensure appropriate use.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote